Primary Site >> Stomach Cancer
Gene >> FGFR3
| 1. | |||||||||||
| Journal: | Clin Cancer Res. 1996 Aug;2(8):1373-81. | ||||||||||
| Title: | Immunohistochemical detection of K-sam protein in stomach cancer. | ||||||||||
| Author: | Hattori, Y|Itoh, H|Uchino, S|Hosokawa, K|Ochiai, A|Ino, Y|Ishii, H|Sakamoto, H|Yamaguchi, N|Yanagihara, K|Hirohashi, S|Sugimura, T|Terada, M | ||||||||||
| PMID: | 9816310 | ||||||||||
| 2. | |||||||||||
| Journal: | Cancer Res. 2001 May 1;61(9):3541-3. | ||||||||||
| Title: | Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers. | ||||||||||
| Author: | Jang, J H|Shin, K H|Park, J G | ||||||||||
| PMID: | 11325814 | ||||||||||
| 3. | |||||||||||
| Journal: | Differentiation. 2007 Nov;75(9):831-42. Epub 2007 Aug 14. | ||||||||||
| Title: | Aberrant fibroblast growth factor receptor signaling in bladder and other cancers. | ||||||||||
| Author: | Chaffer, Christine L|Dopheide, Bonnie|Savagner, Pierre|Thompson, Erik W|Williams, Elizabeth D | ||||||||||
| PMID: | 17697126 | ||||||||||
| 4. | |||||||||||
| Journal: | Prostate. 2011 May;71(6):637-41. | ||||||||||
| Title: | No evidence of FGFR3 mutations in prostate cancer. | ||||||||||
| Author: | Zuiverloon, Tahlita C M|Boormans, Joost L|Trapman, Jan|van Leenders, Geert J L H|Zwarthoff, Ellen C | ||||||||||
| PMID: | 20957671 | ||||||||||
| 5. | |||||||||||
| Journal: | Invest New Drugs. 2012 Aug;30(4):1352-60. | ||||||||||
| Title: | Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks. | ||||||||||
| Author: | Kataoka, Yu|Mukohara, Toru|Tomioka, Hideo|Funakoshi, Yohei|Kiyota, Naomi|Fujiwara, Yutaka|Yashiro, Masakazu|Hirakawa, Kosei|Hirai, Midori|Minami, Hironobu | ||||||||||
| PMID: | 21655918 | ||||||||||
| 6. | |||||||||||
| Journal: | Acta Pharm Hung. 2013;83(2):47-56. | ||||||||||
| Title: | [Developing FGFR inhibitors as potential anti-cancer agents]. | ||||||||||
| Author: | Zsakai, Lilian|Nemeth, Gabor|Szantai-Kis, Csaba|Greff, Zoltan|Horvath, Zoltan|Szokol, Balint|Baska, Ferenc|Boon, Tin Chuad|Orfi, Laszlo|Keri, Gyorgya | ||||||||||
| PMID: | 23926649 | ||||||||||
| 7. | |||||||||||
| Journal: | Med Res Rev. 2014 Mar;34(2):280-300. | ||||||||||
| Title: | FGF receptors: cancer biology and therapeutics. | ||||||||||
| Author: | Katoh, Masaru|Nakagama, Hitoshi | ||||||||||
| PMID: | 23696246 | ||||||||||
| 8. | |||||||||||
| Journal: | Int J Mol Med. 2016 Jul;38(1):3-15. | ||||||||||
| Title: | FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review). | ||||||||||
| Author: | Katoh, Masaru | ||||||||||
| PMID: | 27245147 | ||||||||||
| 9. | |||||||||||
| Journal: | Clin Cancer Res. 2016 Dec 15;22(24):6164-6175. | ||||||||||
| Title: | An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients. | ||||||||||
| Author: | Piro, Geny|Carbone, Carmine|Cataldo, Ivana|Di Nicolantonio, Federica|Giacopuzzi, Simone|Aprile, Giuseppe|Simionato, Francesca|Boschi, Federico|Zanotto, Marco|Mina, Maria Mihaela|Santoro, Raffaela|Merz, Valeria|Sbarbati, Andrea|de Manzoni, Giovanni|Scarpa, | ||||||||||
| PMID: | 27267856 | ||||||||||
| 10. | |||||||||||
| Journal: | Trends Pharmacol Sci. 2016 Dec;37(12):1081-1096. | ||||||||||
| Title: | Therapeutics Targeting FGF Signaling Network in Human Diseases. | ||||||||||
| Author: | Katoh, Masaru | ||||||||||
| PMID: | 27992319 | ||||||||||
| 11. | |||||||||||
| Journal: | Am J Cancer Res. 2017 Jul 1;7(7):1540-1553. eCollection 2017. | ||||||||||
| Title: | Genomic alterations in advanced gastric cancer endoscopic biopsy samples using targeted next-generation sequencing. | ||||||||||
| Author: | Ge, Sai|Li, Beifang|Li, Yanyan|Li, Zhongwu|Liu, Zhentao|Chen, Zuhua|Wu, Jian|Gao, Jing|Shen, Lin | ||||||||||
| PMID: | 28744403 | ||||||||||
| 12. | |||||||||||
| Journal: | Acta Pharmacol Sin. 2018 Feb;39(2):243-250. | ||||||||||
| Title: | SOMCL-085, a novel multi-targeted FGFR inhibitor, displays potent anticancer activity in FGFR-addicted human cancer models. | ||||||||||
| Author: | Jiang, Xi-Fei|Dai, Yang|Peng, Xia|Shen, Yan-Yan|Su, Yi|Wei, Man-Man|Liu, Wei-Ren|Ding, Zhen-Bin|Zhang, Ao|Shi, Ying-Hong|Ai, Jing | ||||||||||
| PMID: | 28905937 | ||||||||||
| 13. | |||||||||||
| Journal: | Genes Chromosomes Cancer. 2018 Sep 21. | ||||||||||
| Title: | Somatic mutational profiles of stage II and III gastric cancer according to tumor microenvironment immune type. | ||||||||||
| Author: | Koh, Jiwon|Nam, Soo Kyung|Roh, Hanseong|Kim, Jonghyuk|Lee, Byung-Chul|Kim, Jin Won|Ahn, Sang-Hoon|Park, Do Joong|Kim, Hyung-Ho|Park, Kyoung Un|Chung, Jin Haeng|Kim, Woo Ho|Lee, Hye Seung | ||||||||||
| PMID: | 30239046 | ||||||||||